<DOC>
	<DOCNO>NCT02740959</DOCNO>
	<brief_summary>This study `` add-on '' study `` main '' study ( Protocol No . : PH-CP012 ) . The information patient main study collect questionnaire survey actigraphy measurement evaluate relationship fatigue , depression sleep disorder efficacy PG2 treatment.The association symptom cluster circadian rhythm also explore .</brief_summary>
	<brief_title>Effects PG2 Fatigue-Related Symptom Clusters</brief_title>
	<detailed_description>The study `` PG2 Treatment Improving Fatigue among Advanced Cancer Patients Standard Palliative Care '' ( Protocol Number : PH-CP012 ) additional plan , questionnaires use actigraphy measure circadian rhythm collect patient data master plan , assess `` PG2 '' treatment cancer patient treatment fatigue , depression , sleep disorder relate symptom resistance effectiveness treatment , explore symptom cluster cancer patient associate circadian rhythm</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<criteria>Patients sign informed consent form The age eligible patient 20 year old . Eligible patient must locally advanced metastatic cancer inoperable advanced cancer . Patients standard palliative care ( SPC ) hospice set curative option available . Patients BFI fatigue score 4 screening . Patients life expectancy least 3 month determine investigator . Patient must willing able complete quality life questionnaire . Female patient pregnant breastfeeding . Patients uncontrolled systemic disease active infection , severe heart disease , uncontrollable hypertension diabetes mellitus . Patients take central nervous system stimulators Methylphenidate within 30 day screen . Patients enrol yet complete investigational drug trial within 30 day screen . Patients Karnofsky Performance Scores less 30 % time screen Patients diagnose die status</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>